首页|布地奈德联合盐酸氨溴索雾化吸入治疗慢性阻塞性肺疾病急性加重期的临床效果分析

布地奈德联合盐酸氨溴索雾化吸入治疗慢性阻塞性肺疾病急性加重期的临床效果分析

扫码查看
目的 探究慢性阻塞性肺疾病(简称慢阻肺)急性加重期患者采取布地奈德联合盐酸氨溴索雾化治疗的临床疗效.方法 便利选取2023年3月—2024年3月涟水县中医院收治的慢阻肺急性加重期患者64例为研究对象,以随机数表法分成两组,各32例.对照组给予布地奈德雾化吸入,观察组在对照组基础上结合盐酸氨溴索雾化吸入.对比两组临床效果、肺功能、炎症因子与不良反应.结果 观察组临床总有效率(96.88%)高于对照组(81.25%),差异有统计学意义(χ2=4.010,P<0.05).治疗后,两组肺功能指标水平显著升高,且观察组高于对照组,差异有统计学意义(P均<0.05);两组炎症因子水平显著降低,且观察组低于对照组,差异有统计学意义(P均<0.05).观察组与对照组不良反应总发生率对比,差异无统计学意义(P>0.05).结论 布地奈德与盐酸氨溴索雾化联合治疗慢阻肺急性加重期的效果可靠,能改善肺功能,减轻炎性反应,且安全性高.
Clinical Effect of Budesonide Combined with Ambroxol Hydrochloride Nebulised Inhalation for Acute Exacerbation of Chronic Obstructive Pul-monary Disease
Objective To explore the efficacy of budesonide combined with ambroxol hydrochloride in patients with acute exacerbation of chronic obstructive pulmonary disease(COPD).Methods A total of 64 patients with acute exac-erbation of COPD admitted to Lianshui County Hospital of Traditional Chinese Medicine from March 2023 to March 2024 were conveniently selected as the research objects,and they were divided into two groups by random number table method,with 32 cases in each group.The control group was given budesonide atomization inhalation,and the ob-servation group was combined with ambroxol hydrochloride atomization inhalation on the basis of the control group.The clinical effects,lung function,inflammatory factors and adverse reactions were compared between the two groups.Result The total effective rate of the observation group(96.88%)was higher than that of the control group(81.25%),and the difference was statistically significant(χ2=4.010,P<0.05).After treatment,the levels of lung function indexes in the two groups increased significantly,and those in the observation group were higher than the control group,the differences were statistically significant(all P<0.05).The levels of inflammatory factors in the two groups were signifi-cantly reduced,and the observation group was lower than the control group,the differences were statistically signifi-cant(all P<0.05).There was no statistically significant difference in the total incidence of adverse reactions between the observation group and the control group(P>0.05).Conclusion The combination of budesonide and ambroxol hydro-chloride atomization in the treatment of the acute exacerbation of COPD is very effective,which can improve lung function,reduce inflammatory factors and have fewer adverse reactions.

Chronic obstructive pulmonary diseaAcute exacerbationBudesonideAmbroxol hydrochlorideNebulizationClinical effect

谷志永

展开 >

涟水县中医院肺病科,江苏 涟水 223400

慢性阻塞性肺疾病 急性加重期 布地奈德 盐酸氨溴索 雾化治疗 临床效果

2024

中外医疗
卫生部医院管理研究所 二十一世纪联合创新医药科学研究院

中外医疗

影响因子:0.909
ISSN:1674-0742
年,卷(期):2024.43(18)